JPS6159308B2 - - Google Patents
Info
- Publication number
- JPS6159308B2 JPS6159308B2 JP7137878A JP7137878A JPS6159308B2 JP S6159308 B2 JPS6159308 B2 JP S6159308B2 JP 7137878 A JP7137878 A JP 7137878A JP 7137878 A JP7137878 A JP 7137878A JP S6159308 B2 JPS6159308 B2 JP S6159308B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- ethyl acetate
- under reduced
- reduced pressure
- alkali metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 21
- -1 alkali metal salts Chemical class 0.000 claims description 13
- 229910052783 alkali metal Inorganic materials 0.000 claims description 8
- OCBFIYONEZGJAF-UHFFFAOYSA-N 1,3-benzoxazol-2-ylmethanesulfonamide Chemical compound C1=CC=C2OC(CS(=O)(=O)N)=NC2=C1 OCBFIYONEZGJAF-UHFFFAOYSA-N 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000001961 anticonvulsive agent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- UBQNRHZMVUUOMG-UHFFFAOYSA-N zonisamide Chemical compound C1=CC=C2C(CS(=O)(=O)N)=NOC2=C1 UBQNRHZMVUUOMG-UHFFFAOYSA-N 0.000 description 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- MOISSRPSFZRNRT-UHFFFAOYSA-N 2-(2-hydroxyphenyl)-2-oxoethanesulfonamide Chemical compound NS(=O)(=O)CC(=O)C1=CC=CC=C1O MOISSRPSFZRNRT-UHFFFAOYSA-N 0.000 description 1
- MAIKTETULSZRED-UHFFFAOYSA-N 3-(bromomethyl)-1,2-benzoxazole Chemical compound C1=CC=C2C(CBr)=NOC2=C1 MAIKTETULSZRED-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 150000008062 acetophenones Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000001339 alkali metal compounds Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000006704 dehydrohalogenation reaction Methods 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7137878A JPS54163570A (en) | 1978-06-12 | 1978-06-12 | Benzooxazole derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7137878A JPS54163570A (en) | 1978-06-12 | 1978-06-12 | Benzooxazole derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS54163570A JPS54163570A (en) | 1979-12-26 |
| JPS6159308B2 true JPS6159308B2 (US20030204162A1-20031030-M00001.png) | 1986-12-16 |
Family
ID=13458770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7137878A Granted JPS54163570A (en) | 1978-06-12 | 1978-06-12 | Benzooxazole derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS54163570A (US20030204162A1-20031030-M00001.png) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS645422U (US20030204162A1-20031030-M00001.png) * | 1987-06-25 | 1989-01-12 | ||
| JPH0415804U (US20030204162A1-20031030-M00001.png) * | 1990-05-30 | 1992-02-07 | ||
| JPH058665Y2 (US20030204162A1-20031030-M00001.png) * | 1986-04-24 | 1993-03-04 | ||
| JP2553774Y2 (ja) * | 1989-11-28 | 1997-11-12 | 東光株式会社 | 電源用トランス |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003020708A1 (en) * | 2001-08-30 | 2003-03-13 | Teva Pharmaceutical Industries Ltd. | Zonisamide intermediate and synthesis |
| US6841683B2 (en) | 2001-08-30 | 2005-01-11 | Teva Pharmaceutical Industries Ltd. | Sulfonation method for zonisamide intermediate in zonisamide synthesis and their novel crystal forms |
| DE60331257D1 (de) | 2003-01-13 | 2010-03-25 | Dainippon Sumitomo Pharma Co | Verfahren zur herstellung von 1,2-dichlorethan freien kristallen von zonisamid und hochreinezonisamidkristalle |
| JP4774192B2 (ja) * | 2003-01-22 | 2011-09-14 | 大日本住友製薬株式会社 | １，２−ジクロロエタンを含まないゾニサミドの結晶の製造方法およびゾニサミドの高純度結晶 |
| US7081539B2 (en) | 2004-03-25 | 2006-07-25 | Dainippon Sumitomo Pharma Co., Ltd. | One-pot process for the preparation of 1,2-benzisoxazole-3-methanesulfonamide |
-
1978
- 1978-06-12 JP JP7137878A patent/JPS54163570A/ja active Granted
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH058665Y2 (US20030204162A1-20031030-M00001.png) * | 1986-04-24 | 1993-03-04 | ||
| JPS645422U (US20030204162A1-20031030-M00001.png) * | 1987-06-25 | 1989-01-12 | ||
| JP2553774Y2 (ja) * | 1989-11-28 | 1997-11-12 | 東光株式会社 | 電源用トランス |
| JPH0415804U (US20030204162A1-20031030-M00001.png) * | 1990-05-30 | 1992-02-07 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS54163570A (en) | 1979-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bodor et al. | A convenient synthesis of (acyloxy) alkyl. alpha.-ethers of phenols | |
| BR112020018562A2 (pt) | Processo preparativo | |
| JPS6033114B2 (ja) | １，２−ベンズイソキサゾ−ル誘導体 | |
| NO141756B (no) | Analogifremgangsmaate for fremstilling av antiparasittisk aktive salicylanilidderivater | |
| JPS6159308B2 (US20030204162A1-20031030-M00001.png) | ||
| WO2015079018A1 (en) | Synthesis of vortioxetine via (2-(piperazine-1 -yl)phenvl)lithium intermediates | |
| US4340599A (en) | Phosphono-hydroxy-acetic acid and its salts, their production and their medicinal use | |
| JPS6119621B2 (US20030204162A1-20031030-M00001.png) | ||
| JP2018527324A (ja) | ガンを処置するのに使用するための置換疎水性ベンゼンスルホンアミドチアゾール化合物 | |
| SE531698C2 (sv) | Nya bronkdilaterande a,b-omättade amider | |
| JPS59104364A (ja) | 新規ピリミジン誘導体およびその製造法 | |
| JP3477631B2 (ja) | １，３−ビス（３−アミノプロピル）−１，１，３，３−テトラオルガノジシロキサンの精製方法 | |
| Kolenc et al. | Application of oximes for the transfer of a CH fragment | |
| JPH08333340A (ja) | アミノエチルピペリジン誘導体の製造方法 | |
| JP3066594B2 (ja) | アニリン誘導体及びその製造法 | |
| WO1994019316A1 (en) | New compounds | |
| US3158622A (en) | Nu-benzyl-nu-(1, 4-benzodioxan-2-methyl)-hydrazine and corresponding hydrazones | |
| JPS5813550B2 (ja) | シンキナピリド （ ４，３−ｄ ） ピリミジンジオンユウドウタイノセイゾウホウ | |
| JPH0220638B2 (US20030204162A1-20031030-M00001.png) | ||
| EP0013726B1 (en) | Indanyloxamic derivatives, their preparation and pharmaceutical compositions containing them | |
| JPH0155267B2 (US20030204162A1-20031030-M00001.png) | ||
| JP3489009B2 (ja) | ホスホン酸ジエステル誘導体 | |
| RU2015964C1 (ru) | Способ получения замещенных производных амина | |
| JP3495774B2 (ja) | １−ヒドロキシインドール類の製法 | |
| Matysiak et al. | Nucleosides. Part LXIII. Acetals as new 2′‐O‐protecting functions for the synthesis of oligoribonucleotides: Synthesis of uridine building blocks and evaluation of their relative acid stability |
